CABAZITAXEL TILLOMED 60 mg, solution for dilution and solvent for solution for infusion bottle, 1.5 ml
Active ingredients: Cabazitaxel
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for dilution and solvent for concentrate for infusionbottle, 1.5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CABAZITAXEL TILLOMED 60 mg, solution à diluer et solvant pour solution pour perfusion
- Pharmaceutical form
- solution à diluer et solvant pour solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 1,5 mL de solution - 1 flacon(s) en verre de 5,67 mL de solvant
- Marketing authorisation holder
- TILLOMED PHARMA (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 27 Dec 2024
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63010901CIP75509265CIP133400955092650Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CABAZITAXELsolution | 60 mg · un flacon de 1,5 mL de solution à diluer | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.